Conference abstract · 1 Dec 2019
Conference abstractPublished 28 Nov 2013
How to develop and assess innovative medication safety clinical programs
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: It is well recognized that medication errors occur and can affect success in treating patients. Programs in Germany using the teacher-practitioner model and an HIV/AIDS service in the USA are few of the clinical programs developed and assessed. Objectives: In both programs the objective was to 1) determine the incidence medication errors; and 2) describe the nature and cause(s) of errors to guide future programs. Methods: In 1 program 10 student-paired groups were used as extenders on an internal medicine ward in 3 consecutive 4- hour long blocks using a paper-based system. In another program a daily antiretroviral utilization report was used to identify adults who were receiving ART, and had been admitted to a tertiary care teaching hospital during 2 consecutive months in 2005. Patients? charts, medication profiles, and medication administration records were reviewed for medication errors. Once identified, etiology and cause were further investigated through interviews. Results: In the first example, 29 actual drug-related problems were identified in 9 patients, median age of 71, range 51-88. There was an average of three drug-related problems per patient, range 1-5. In the later study 69 combined ART- and (OI)-related medication errors were identified in 20 of 26 (77%) evaluated patients, with 2.7 medication errors per patient with 54% of the errors occurred within the first 24 hours of admission. Inadequate medication reconciliation on admission caused 21 of 37 (57%) admission related errors. The most prevalent error types included missing doses (20%), under-dosing (13%), over-dosing (13%), therapy omission (13%), and drug-drug interaction (12%). Conclusions: Prospective investigation of potential for medication errors provided in-depth insight into the diverse nature of medication errors, risk factors and potential preventive strategies of the errors. Various approaches can be used based on resources and primary concerns. Maintaining the service and re- evaluation of the changes is possible.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 16 Jul 2018
Development of medical safety data reporting programs and health education centers
Article · 29 Mar 2024
Balancing Innovation and Safety: Ethical Considerations in Expedited Drug Approval Programs
Conference abstract · 10 Oct 2016
Medication safety unit programs in King Saud Medical City, 2012-2013: Safe medication management and use with a focus on patient safety
Editorial · 2015
National Medication Safety Program at Ministry of Health in Saudi Arabia
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ann Marie Snyder”
